*It may take a few minutes for the email to arrive.
**Be sure to check your spam/junk folder.
Ospemifene is an oral medication for menopausal women that helps reduce pain during sex by improving the health of vaginal tissues.
Ospemifene is a medication approved by the FDA for the treatment of moderate to severe dyspareunia (painful intercourse), a symptom of genitourinary syndrome of menopause (GSM). GMS describes the various menopausal symptoms and signs associated with physical changes of the vulva, vagina, and lower urinary tract. GSM includes not only genital symptoms (dryness, burning, and irritation) and sexual symptoms (lack of lubrication, discomfort or pain, and impaired function), but also urinary symptoms (urgency, dysuria, and recurrent urinary tract infections [UTIs]). [1] Doctor of Pharmacy and therapeutic expert, Audrey Hou, explains why Ospemifene offers an alternative for women seeking relief from dyspareunia without using traditional estrogen-based therapies.
Ospemifene is classified as a selective estrogen receptor modulator (SERM). Unlike traditional estrogen therapy that adds estrogen to the body, SERMs selectively mimic or block estrogen’s effects on different tissues. Ospemifene works by mimicking the effects of estrogen on the vaginal tissue, which helps rebuild the tissue, making it thicker and less fragile, thereby reducing pain during intercourse.
Ospemifene is taken orally, typically once a day. If you miss a dose, wait until your next regularly scheduled pill. As with any medication, it’s important to use ospemifene under the guidance of a healthcare provider, following the prescribed dosage and regimen closely. The effectiveness and any side effects should be regularly reviewed with your provider.
Common side effects of ospemifene may include hot flashes, vaginal discharge, and sweating. There are also potential risks associated with ospemifene, including an increased chance of developing endometrial hyperplasia, which could lead to cancer of the lining of the uterus if left untreated. Women using ospemifene are advised to report any unusual vaginal bleeding to their healthcare provider since it could be a sign of endometrial hyperplasia or cancer. Because of its selective action, ospemifene may not be suitable for all women, especially those at increased risk for blood clots or stroke.
Ospemifene offers an important treatment option for postmenopausal women experiencing painful intercourse due to vaginal atrophy. By mimicking the effects of estrogen on vaginal tissue, it can provide relief from one of the more challenging symptoms of menopause without the use of traditional hormone replacement therapy. As with any medication, careful consideration and ongoing communication with a healthcare provider are key to maximizing the benefits of ospemifene while managing potential risks.
References:
There is no reason to suffer. Get help today. Find a menopause-specific doctor or healthcare expert near you to help support your perimenopause and menopause journey.